CA3191653A1 - Mepyramine for use in the topical treatment of neuropathic pain - Google Patents
Mepyramine for use in the topical treatment of neuropathic painInfo
- Publication number
- CA3191653A1 CA3191653A1 CA3191653A CA3191653A CA3191653A1 CA 3191653 A1 CA3191653 A1 CA 3191653A1 CA 3191653 A CA3191653 A CA 3191653A CA 3191653 A CA3191653 A CA 3191653A CA 3191653 A1 CA3191653 A1 CA 3191653A1
- Authority
- CA
- Canada
- Prior art keywords
- topical composition
- neuropathy
- mepyramine
- neuropathic pain
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20306009.0 | 2020-09-11 | ||
| EP20306009.0A EP3967308A1 (en) | 2020-09-11 | 2020-09-11 | Mepyramine for use in the topical treatment of neuropathic pain |
| PCT/EP2021/074906 WO2022053598A1 (en) | 2020-09-11 | 2021-09-10 | Mepyramine for use in the topical treatment of neuropathic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3191653A1 true CA3191653A1 (en) | 2022-03-17 |
Family
ID=72615785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3191653A Pending CA3191653A1 (en) | 2020-09-11 | 2021-09-10 | Mepyramine for use in the topical treatment of neuropathic pain |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230321059A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3967308A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023540355A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230083272A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021342331A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3191653A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022053598A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026119772A1 (fr) | 2024-12-02 | 2026-06-11 | Assistance Publique Hopitaux De Paris | Nanoparticules de mepyramine et de squalene |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8521342D0 (en) * | 1985-08-27 | 1985-10-02 | Univ Glasgow | Medicament |
| EP0351897A3 (en) * | 1988-06-17 | 1990-03-21 | The Procter & Gamble Company | Skin penetration system for salts of amine-functional drugs |
| US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
-
2020
- 2020-09-11 EP EP20306009.0A patent/EP3967308A1/en not_active Withdrawn
-
2021
- 2021-09-10 WO PCT/EP2021/074906 patent/WO2022053598A1/en not_active Ceased
- 2021-09-10 JP JP2023515153A patent/JP2023540355A/ja active Pending
- 2021-09-10 US US18/025,052 patent/US20230321059A1/en not_active Abandoned
- 2021-09-10 EP EP21773791.5A patent/EP4210699A1/en not_active Withdrawn
- 2021-09-10 AU AU2021342331A patent/AU2021342331A1/en not_active Abandoned
- 2021-09-10 KR KR1020237008699A patent/KR20230083272A/ko active Pending
- 2021-09-10 CA CA3191653A patent/CA3191653A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230321059A1 (en) | 2023-10-12 |
| WO2022053598A1 (en) | 2022-03-17 |
| JP2023540355A (ja) | 2023-09-22 |
| EP3967308A1 (en) | 2022-03-16 |
| KR20230083272A (ko) | 2023-06-09 |
| EP4210699A1 (en) | 2023-07-19 |
| AU2021342331A1 (en) | 2023-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004007225T2 (de) | Methode zur behandlung von erkrankungen der unteren harnwege | |
| ES2812532T3 (es) | Compuestos, formulaciones y procedimientos para tratar o prevenir la rosácea | |
| JP4970685B2 (ja) | 眼痛の処置方法 | |
| US20100184817A1 (en) | Methods of treating neuropathy | |
| JP2010537988A (ja) | 紅斑を治療するための改良ブリモニジン組成物 | |
| KR20190004815A (ko) | 안과 치료제 | |
| CN101977605A (zh) | 雷诺嗪治疗疼痛的用途 | |
| EP3551166B1 (en) | Topical phenytoin for use in the treatment of peripheral neuropathic pain | |
| AU2002310788B2 (en) | Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists | |
| DE60315258T2 (de) | Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals | |
| JP2024012412A (ja) | 局所と局部の麻酔と鎮痛 | |
| KR20010021854A (ko) | 말초 작용성 항소양성 아편제 | |
| US20230321059A1 (en) | Mepyramine for use in the topical treatment of neuropathic pain | |
| US9187468B2 (en) | Topical ocular analgesic agents | |
| KR20250004041A (ko) | 삼차 신경통 치료 및 그와 관련된 통증 감소에 사용하기 위한 트리메프라진 | |
| SK7832000A3 (en) | New use of local anaesthetics against vascular headaches | |
| US20070105940A1 (en) | Method for treating pain | |
| US20080255238A1 (en) | Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases | |
| JP2000515865A (ja) | 過剰攻撃を処置する方法 | |
| WO2006087481A1 (fr) | Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 | |
| HK40015081A (en) | Topical phenytoin for use in the treatment of peripheral neuropathic pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240904 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240904 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240904 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260225 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260226 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-6-6-B10-B12-B301 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO A REQUEST FOR EXAMINATION NOTICE Effective date: 20260427 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20260427 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260709 |